Literature DB >> 9437317

Ten-year follow-up of helium ion therapy for uveal melanoma.

D H Char1, S M Kroll, J Castro.   

Abstract

PURPOSE: To examine the results of helium ion irradiation in 218 patients with uveal melanoma treated more than 10 years ago.
METHOD: A retrospective review was made of 218 patients (218 eyes) treated with helium ion radiation for uveal melanoma between 1978 and 1984.
RESULTS: After helium ion irradiation, 208 (95.4%) of 218 eyes had local tumor control. Ten years after irradiation, 46 (22.4%) of 218 eyes had been enucleated; the majority of enucleations (37 of 46) resulted from anterior ocular segment complications. Ten years after radiation, 102 (46.8%) of the 218 patients were dead; 51 had non-melanoma-related deaths and 51 had died of metastatic melanoma. Best-corrected visual acuity after radiation was greater than 20/40 in 21 (23%) of 93 eyes of the patients who were alive and who had retained their eyes 10 or more years after treatment. In patients with tumors less than 6 mm in height and more than 3 mm distant from the nerve or the fovea, 13 (72%) of 18 retained visual acuity greater than 20/40. In contrast, only 11% of the patients with either thicker tumors or those close to the nerve or fovea retained that level of visual acuity.
CONCLUSIONS: Helium ion irradiation of uveal melanoma is associated with good local tumor control and reasonable retention of the treated eye 10 years after treatment. In eyes with tumors less than 6 mm in thickness and more than 3 mm distant from the optic nerve and fovea, many retain excellent vision.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9437317     DOI: 10.1016/s0002-9394(99)80238-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Eye-wall resection.

Authors:  D H Char; T Miller; J B Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  2000

2.  Uveal tumour resection.

Authors:  D H Char; T Miller; J B Crawford
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  Uveal melanoma: molecular pattern, clinical features, and radiation response.

Authors:  Michael C Chappell; Devron H Char; Tia B Cole; J William Harbour; Kavita Mishra; Vivian K Weinberg; Theodore L Phillips
Journal:  Am J Ophthalmol       Date:  2012-04-27       Impact factor: 5.258

4.  Intraocular inflammation after proton beam irradiation for uveal melanoma.

Authors:  L Lumbroso; L Desjardins; C Levy; C Plancher; E Frau; F D'Hermies; P Schlienger; H Mammar; S Delacroix; C Nauraye; R Ferrand; C Desblancs; A Mazal; B Asselain
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

5.  Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.

Authors:  Devron H Char; Riley Bove; Theodore L Phillips
Journal:  Trans Am Ophthalmol Soc       Date:  2003

6.  Interobserver and intraobserver variability of measurements of uveal melanomas using standardised echography.

Authors:  C Haritoglou; A S Neubauer; H Herzum; W R Freeman; A J Mueller
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 7.  Local treatment failure after globe-conserving therapy for choroidal melanoma.

Authors:  Melinda Y Chang; Tara A McCannel
Journal:  Br J Ophthalmol       Date:  2013-05-03       Impact factor: 4.638

8.  Prognostic factors of choroidal melanoma in Slovenia, 1986-2008.

Authors:  Boris Jancar; Marjan Budihna; Brigita Drnovsek-Olup; Katrina Novak Andrejcic; Irena Brovet Zupancic; Dusica Pahor
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

9.  Atypical Presentation: Metastatic Uveal Melanoma in a Young Patient without Visual Complaints.

Authors:  Pedro Grachinski Buiar; Sérgio Jobim de Azevedo
Journal:  Front Oncol       Date:  2017-05-18       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.